Is CoStar Group, Inc. overvalued or undervalued?
As of October 24, 2025, CoStar Group, Inc. is considered overvalued with a high P/E ratio of 283 and an EV to EBITDA ratio of 202.31, significantly exceeding industry peers, and has underperformed the S&P 500, indicating a less favorable investment outlook.
As of 24 October 2025, the valuation grade for CoStar Group, Inc. has moved from fair to attractive, indicating a more favorable assessment. The company appears to be overvalued, primarily reflected in its high P/E ratio of 283, significantly above the industry average, and an EV to EBITDA ratio of 202.31, which suggests that investors are paying a premium for earnings before interest, taxes, depreciation, and amortization. Additionally, the Price to Book Value stands at 3.87, further supporting the notion of overvaluation.In comparison to its peers, CoStar Group's P/E ratio is notably higher than VeriSign, Inc. at 33.05 and Check Point Software Technologies Ltd. at 53.34, both of which are in the same industry. Furthermore, the company has underperformed against the S&P 500 over various time frames, with a 3-year return of 9.10% compared to the S&P 500's 78.85%, reinforcing the view that it may be overvalued relative to its growth prospects.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
